References
- Revicki DA, Kleinman L, Cella D. A history of health-related quality of life outcomes in psychiatry. Dialogues Clin Neurosci. 2014;16(2):127–35.
- Guyatt GH, Ferrans CE, Halyard MY, et al., editors. Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. Mayo Clinic Proc. 2007;82(10):1229–39.
- Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? PharmacoEconomics. 2016;34(7):645–649. doi: 10.1007/s40273-016-0389-9
- Brown DS, Jia H, Zack MM, et al. Using health-related quality of life and quality-adjusted life expectancy for effective public health surveillance and prevention. Expert Rev Pharmacoecon Outcomes Res. 2013;13(4):425–427. doi: 10.1586/14737167.2013.818816
- Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann internal med. 1993;118(8):622–629. doi: 10.7326/0003-4819-118-8-199304150-00009
- Coons SJ, Rao S, Keininger DL, et al. A comparative review of generic quality-of-life instruments. PharmacoEconomics. 2000;17(1):13–35. doi: 10.2165/00019053-200017010-00002
- Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med care. 1989;27(Supplement):S217–S32. doi: 10.1097/00005650-198903001-00018
- Devlin NJ, Krabbe PF. The development of new research methods for the valuation of EQ-5D-5L. Eur J Health Econ. 2013;14(Suppl 1):1–3. doi: 10.1007/s10198-013-0502-3
- Buchholz I, Janssen MF, Kohlmann T, et al. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. PharmacoEconomics. 2018;36(6):645–661. doi: 10.1007/s40273-018-0642-5
- Rabin R, Fd C. EQ-SD: a measure of health status from the EuroQol group. Ann Med. 2001;33(5):337–343. doi: 10.3109/07853890109002087
- Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736. doi: 10.1007/s11136-011-9903-x
- Szende A, Janssen B, Cabases J. Self-Reported Population Health: An International Perspective Based on EQ-5D. Springer; 2014.
- Devlin N, Roudijk B, Ludwig K. Value sets for EQ-5D-5L: a compendium, comparative review & user guide. Berlin: Springer; 2022.
- Golicki D, Niewada M, Karlińska A, et al. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients. Qual Life Res. 2015;24(6):1555–1563. doi: 10.1007/s11136-014-0873-7
- Feng Y, Parkin D, Devlin NJ. Assessing the performance of the EQ-VAS in the NHS PROMs programme. Qual Life Res. 2014;23(3):977–989. doi: 10.1007/s11136-013-0537-z
- Akbari Sari A, Karimi F, Emrani Z, et al. The impact of common chronic conditions on health-related quality of life: a general population survey in Iran using EQ-5D-5L. Cost Eff Resour Allocation. 2021;19(1):28. doi: 10.1186/s12962-021-00282-8
- Emrani Z, Akbari Sari A, Zeraati H, et al. Health-related quality of life measured using the EQ-5D–5 L: population norms for the capital of Iran. Health Qual Life Outcomes. 2020;18(1):1–8. doi: 10.1186/s12955-020-01365-5
- Karyani AK, Rashidian A, Sefiddashti SE, et al. Self-reported health-related quality of life (HRQoL) and factors affecting HRQoL among individuals with health insurance in Iran. Epidemiol Health. 2016;38:e2016046. doi: 10.4178/epih.e2016046
- Afshari S, Daroudi R, Goudarzi R, et al. A national survey of Iranian general population to estimate a value set for the EQ-5D-5L. Qual Life Res. 2023;32(7):1–9. doi: 10.1007/s11136-023-03378-1
- Goudarzi R, Sari AA, Zeraati H, et al. Valuation of quality weights for EuroQol 5-dimensional health states with the time trade-off method in the capital of Iran. Value Health Reg Issues. 2019;18:170–175. doi: 10.1016/j.vhri.2019.01.007
- Janssen M, Szende A, Cabases J, et al. Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries. Eur J Health Econ. 2019;20(2):205–216. doi: 10.1007/s10198-018-0955-5
- The World Bank. 2023. Available from: https://data.worldbank.org/country/iran-islamic-rep.
- Djalalinia S, Azadnajafabad S, Ghasemi E, et al. Protocol design for surveillance of risk factors of non–communicable diseases during the COVID-19 pandemic: an experience from Iran STEPS survey 2021. Arch Iran Med. 2022;25(9):634–646. doi: 10.34172/aim.2022.99
- Yang Z, Busschbach J, Liu G, et al. EQ-5D-5L norms for the urban Chinese population in China. Health Qual Life Outcomes. 2018;16(1):1–9. doi: 10.1186/s12955-018-1036-2
- Grochtdreis T, Dams J, König H-H, et al. Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set. Eur J Health Econ. 2019;20(6):933–944. doi: 10.1007/s10198-019-01054-1
- Encheva M, Djambazov S, Vekov T, et al. EQ-5D-5L Bulgarian population norms. Eur J Health Econ. 2020;21(8):1169–1178. doi: 10.1007/s10198-020-01225-5
- Ferreira PL, Pereira LN, Antunes P, et al. EQ-5D-5L Portuguese population norms. Eur J Health Econ. 2023;24(9):1–10. doi: 10.1007/s10198-022-01552-9
- Santos M, Monteiro AL, Santos B. EQ-5D Brazilian population norms. Health Qual Life Outcomes. 2021;19(1):162. doi: 10.1186/s12955-021-01671-6
- McCaffrey N, Kaambwa B, Currow DC, et al. Health-related quality of life measured using the EQ-5D–5L: South Australian population norms. Health Qual Life Outcomes. 2016;14(1):1–12. doi: 10.1186/s12955-016-0537-0
- Statistical power analysis for the behavioral sciences. New Jersey: Lawrence Erlbaum Associates; 1988.
- Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461–494. doi: 10.1016/S0167-6296(01)00086-8
- Golicki D, Niewada M. EQ-5D-5L Polish population norms. Arch Med Sci. 2017;13(1):191–200. doi: 10.5114/aoms.2015.52126
- Scalone L, Cortesi PA, Ciampichini R, et al. Health related quality of life norm data of the Italian general population: results using the EQ-5D-3L and EQ-5D-5L instruments. Epidemiology Biostatistics Public Health. 2015;12(3). doi: 10.2427/11457
- Sullivan T, Turner RM, Derrett S, et al. New Zealand population norms for the EQ-5D-5L constructed from the personal value sets of participants in a national survey. Value Health. 2021;24(9):1308–1318. doi: 10.1016/j.jval.2021.04.1280
- Hinz A, Kohlmann T, Stöbel-Richter Y, et al. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res. 2014;23(2):443–447. doi: 10.1007/s11136-013-0498-2
- Shiroiwa T, Fukuda T, Ikeda S, et al. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25(3):707–719. doi: 10.1007/s11136-015-1108-2
- Hinz A, Klaiberg A, Brähler E, et al. The quality of life questionnaire EQ-5D: modelling and norm values for the general population. Psychother Psychosom Med Psychol. 2006;56(2):42–48. doi: 10.1055/s-2005-867061
- Thompson AJ, Turner AJ. A comparison of the EQ-5D-3L and EQ-5D-5L. PharmacoEconomics. 2020;38(6):575–591. doi: 10.1007/s40273-020-00893-8
- Goudarzi R, Zeraati H, Sari AA, et al. Population-based preference weights for the EQ-5D health states using the visual analogue scale (VAS) in Iran. Iran Red Crescent Med J. 2016;18(2). doi: 10.5812/ircmj.21584
- Mosadeghrad AM, Mousavi A. The futurology of aging population in Iran: letter to the editor. Tehran Univ Med J. 2021;79(3):248–249.